General
Commercial starting materials and solvents were used without further purification, unless otherwise stated. THF was freshly distilled from sodium/benzophenone. TLC was performed on TLC silica gel 60 F254 plates and visualized at 254 or 365 nm or by staining with phosphomolybdic acid, ninhydrin, or KMnO4 stains. Purification by flash chromatography was carried out using silica gel 60 (0.040-0.063 mm, Merck). 1 H and 13 C NMR spectra were recorded at 400 and 101MHz, respectively, on a Bruker Avance III 400 at 300 K. HPLC analysis was performed using a Gemini C18 column (5 μm, 4.6x150 mm); flow: 1 mL/min; 10% MeCN in water (0-1 min), 10-100% MeCN in water (1-10 min), 100% MeCN (11-15 min), with both solvents containing 0.1% HCOOH as modifier; UV detection at 254 nm. High-resolution mass spectra (HRMS) were obtained on a Bruker micrOTOF-Q II (ESI).
Sequences of BRAF dsDNA was obtained from pubmed genbank public database (Gene ID: 673). The complementary DNA sequences were purchased from IDT Integrated DNA Technologies.
UV-vis and fluorescence spectra were recorded on DU®800 spectrophotometer, Beckman Coulter and LS 55 Perkin Elmer spectrofluorimeter, respectively. The presented values are the average of two independent measurements with result deviation below 3%.
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Concentrations of proteins and antibodies were measured by OD280 at Nanodrop (Thermo Fisher Scientific). LOD was calculated as the lowest concentration of the target at a given concentration of a reagent at which the signal to noise ratio was above 3. 
Fluorophore synthesis and characterization

Synthesis
Compound 3.
4-(Furan-2-yl)-2-methyl-5-oxo-N-phenyl-1,4,5,6,7,8-hexahydroquinoline-3-carboxamide.
A microwave vial under an argon atmosphere was charged with 3-aminocyclohex-2-en-1-one (56 mg, 0.50 mmol), furan-2-carbaldehyde (0.40 μL, 0.48 mmol), 3-oxo-N-(o-tolyl)butanamide (91 mg, 0.52 mmol) and IPA (2.5 mL). The vial was flushed with argon, capped, and the reaction stirred at 80 o C for one day. After completion, the reaction was cooled to room temperature and concentrated in vacuo. The residue was purified by flash column chromatography (EtOAc:petroleum ether, Furan-2-carbaldehyde precursors.
5-Phenylfuran-2-carbaldehyde.
A schlenck flask under argon atmosphere was charged with 5-bromofuran-2-carbaldehyde (175 mg, 1.00 mmol), phenylboronic acid (135 mg, 1.11 mmol), Pd-XPhos-G4 (18 mg, 0.02 mmol) and THF (5 mL), and the reaction was degassed. Aqueous 0.5M K3PO4 (4 mL) was added and the mixture was degassed once more and stirred at room temperature for 22 hours. After completion, the reaction mixture was diluted with water and extracted with EtOAc (x3). The organic phases were combined, washed with brine, dried over Na2SO4, and concentrated in vacuo. 
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Compound 8.
4-(5-(4-Methoxyphenyl)furan-2-yl)-2-methyl-5-oxo-N-phenyl-1,4,5,6,7,8-hexahydroquinoline-3-carboxamide.
A 10 mL microwave vial was charged with 5-(4-methoxyphenyl)furan-2-carbaldehyde (168 mg, 0.83 Fluorophore characterization. UV-vis spectra were recorded on DU®800 spectrophotometer (Beckman Coulter). For individual fluorophores, 1 µM solutions in 5% DMSO-1xPBS buffer were used. For fluorophore-biomolecule mixtures, the analysis was carried out in 0.5% DMSO-1x PBS buffer (pH 7.2), using 5 nM CTD/BSA and 1 µM fluorophores. All the samples were analyzed twice with deviation in the resulting values (molar extinction and position of maxima) within 2%.
To study influence of biomolecules on fluorescence the solution of a corresponding dye was added to 1 mM solution of calf thymus DNA (CTD) or bovine serum albumin (BSA) in 1x PBS (pH 7.2).
Final concentration of the dye in each sample was 100 nM. The resulting mixture was gently shaken and kept at room temperature for 1 h prior to measurements.
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Fluorescence spectra were recorded on LS 55 fluorometer (Perkin Elmer), using diluted samples with the maximal absorbance not exceeding 0.1. 
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3.
Tm and CD studies of DNA-fluorophore complexes
Probe annealing
The annealing was made in solution of 1xPBS, pH 7.2, 10 min at 95°C followed by cooling to room temperature over 4 hr.
Double-stranded DNA used in this study: (5'-TGT GGT AGT TGA GCG GAT GGC GTA GGC A -3'): (5'-TGC CTA CGC CAT CCG CTC AAC TAC CAC A -3').
Tm measurements
Studies were carried out in 100 mM TRIS buffer (pH 7.5), using DU®800 spectrophotometer (Beckman Coulter). All ds samples were analyzed twice in a concentration 0.5 μM for the dsDNA.
The dyes were added to the DNA solution and kept 1 h at room temperature prior to measurement. Table S3 . Tm data for model dsDNA and the dyes.
Sample details
Tm, °C dsDNA 72 dsDNA+fluorophore 3 (4 eq) 72 dsDNA+ fluorophore 4 (4 eq) 72 dsDNA+ fluorophore 5 (4 eq) 72 dsDNA+ fluorophore 3 (1 eq) 72 dsDNA+ fluorophore 5 (1 eq) 72 Each value is an average of two independent measurements with result deviation < 1.0 °C
Circular dichroism measurements
CD measurements were performed in 100 mM TRIS buffer (pH 7.5) using JASCO J-815 CD Spectrometer equipped with CDF4565/15 temperature controller. The solutions had a concentration of 2 μM DNA and 2 μM or 8 μM dye. Representative spectra are shown in Supplementary Figure S3 . 
DNA origami preparation, characterization and studies of origamifluorophore complexes
The mixtures of ss primers and M13 bacteriophage ss DNA were annealed following published procedure. 2 In brief, 10 nM DNA samples in 1x TAE buffer with 12 mM MgCl2 were placed in thermocycler and incubated using the following conditions: lid 100 °C, 90 °C 2 min, 90→60 decrease 0.5 °C pr 1 min, 60→50 decrease 0.2 °C pr 10 min, 50→35 decrease 0.5 °C pr 1 min; store at room temperature or 10 °C.
Complexes of fluorophores with diverse origami structures were prepared by adding 5, 8 or Eva
Green to the annealing reactions at the desired concentration at 60 °C (see annealing protocol described above). 
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Statistical analyses
Statistical analyses (one-way ANOVA, linear regression) were carried out in R. Clinical parameters were selected based on the positivity shown in the Table S11 . Control group was double negative by immunofluorescence (n=10; randomly selected from the SLE cohort). P values below 0.05 were considered statistically significant (95% confidence level).
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Supplementary Table S11 
